CONTROL OF ANTIDONOR ANTIBODY PRODUCTION WITH TACROLIMUS AND MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTS WITH CHRONIC REJECTION1
Tom P. Theruvath(Massachusetts General Hospital), Manuel Pascual(University of Lausanne), Susan L. Saidman(Harvard University), Shamila Mauiyyedi(Massachusetts General Hospital), A. Bernard Collins(Massachusetts General Hospital), Nina Tolkoff-Rubin(Harvard University), A. Benedict Cosimi(Harvard University), Winfred W. Williams, Francis L. Delmonico, Robert B. Colvin(Harvard University)
Cited by 154
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k
International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology
|Kidney International|1993|1.5k
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
|American Journal of Transplantation|2014|1.3k